| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VACCINE.2006.10.002 |
| P698 | PubMed publication ID | 17081662 |
| P2093 | author name string | Li Y | |
| De Serres G | |||
| Petric M | |||
| Mak A | |||
| Tam T | |||
| Chong M | |||
| Kwindt TL | |||
| Masaro C | |||
| Sebastian R | |||
| Skowronski DM | |||
| P2860 | cites work | Estimation of influenza vaccine effectiveness using routine surveillance data | Q31032010 |
| Simultaneous detection of influenza viruses A and B using real-time quantitative PCR. | Q33970922 | ||
| Evidence of bias in estimates of influenza vaccine effectiveness in seniors | Q34478438 | ||
| Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors | Q34563585 | ||
| Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications | Q35013711 | ||
| Longitudinal analysis of genotype distribution of influenza A virus from 2003 to 2005. | Q38479480 | ||
| Methodological quality of studies and patient age as major sources of variation in efficacy estimates of influenza vaccination in healthy adults: a meta-analysis. | Q40489726 | ||
| Clinical and immunologic evaluation of neuraminidase-specific influenza A virus vaccine in humans | Q40883203 | ||
| Evaluation of a Neuraminidase-Specific Influenza A Virus Vaccine in Children: Antibody Responses and Effects on Two Successive Outbreaks of Natural Infection | Q41179647 | ||
| Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons | Q43209729 | ||
| Infection-permissive immunization with influenza virus neuraminidase prevents weight loss in infected mice | Q43705692 | ||
| Effectiveness of influenza vaccine in the elderly | Q44185467 | ||
| Protection of mice with recombinant influenza virus neuraminidase | Q45072351 | ||
| Annual revaccination against influenza and mortality risk in community-dwelling elderly persons | Q47901153 | ||
| T cell responses are better correlates of vaccine protection in the elderly | Q83276474 | ||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Canada | Q16 |
| vaccine | Q134808 | ||
| laboratory | Q483242 | ||
| P304 | page(s) | 2842-2851 | |
| P577 | publication date | 2006-10-16 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. | |
| P478 | volume | 25 |
| Q57452617 | A Dynamic Model for Evaluation of the Bias of Influenza Vaccine Effectiveness Estimates from Observational Studies |
| Q47162930 | A comparison of the test-negative and the traditional case-control study designs for estimation of influenza vaccine effectiveness under nonrandom vaccination |
| Q64137151 | A comparison of the test-negative and traditional case-control study designs with respect to the bias of estimates of rotavirus vaccine effectiveness |
| Q37130821 | A comprehensive review of the epidemiology and disease burden of Influenza B in 9 European countries |
| Q30377766 | A paradigm shift in vaccine production for pandemic influenza. |
| Q35109002 | A probability model for evaluating the bias and precision of influenza vaccine effectiveness estimates from case-control studies. |
| Q47843797 | A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season |
| Q30377217 | A vaccine manufacturer's approach to address medical needs related to seasonal and pandemic influenza viruses |
| Q30397257 | Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England |
| Q30417900 | Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom |
| Q35723417 | An Assessment of the Expected Cost-Effectiveness of Quadrivalent Influenza Vaccines in Ontario, Canada Using a Static Model |
| Q57465318 | Anamnestic Immune Response and Safety of an Inactivated Quadrivalent Influenza Vaccine in Primed Versus Vaccine-Naïve Children |
| Q37015490 | Antigenic Characterization of H3 Subtypes of Avian Influenza A Viruses from North America |
| Q30408239 | Assessing the impact of confounding (measured and unmeasured) in a case-control study to examine the increased risk of pandemic A/H1N1 associated with receipt of the 2008-9 seasonal influenza vaccine |
| Q38864751 | Assessment of Virus Interference in a Test-negative Study of Influenza Vaccine Effectiveness |
| Q30388012 | Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada |
| Q21142689 | Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidases |
| Q92125270 | Bias of influenza vaccine effectiveness estimates from test-negative studies conducted during an influenza pandemic |
| Q89965369 | Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics |
| Q92915035 | Can routinely collected laboratory and health administrative data be used to assess influenza vaccine effectiveness? Assessing the validity of the Flu and Other Respiratory Viruses Research (FOREVER) Cohort |
| Q30857100 | Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example |
| Q51119248 | Co-morbidities associated with influenza-attributed mortality, 1994-2000, Canada. |
| Q51155060 | Comparison of influenza vaccine effectiveness using different methods of case detection: clinician-ordered rapid antigen tests vs. active surveillance and testing with real-time reverse-transcriptase polymerase chain reaction (rRT-PCR). |
| Q48071872 | Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. |
| Q30217321 | Cost-effectiveness of alternative strategies for annual influenza vaccination among children aged 6 months to 14 years in four provinces in China |
| Q35886955 | Cost-effectiveness of quadrivalent influenza vaccine in Hong Kong - A decision analysis. |
| Q30373099 | Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14. |
| Q35956533 | Detailed Report on 2014/15 Influenza Virus Characteristics, and Estimates on Influenza Virus Vaccine Effectiveness from Austria's Sentinel Physician Surveillance Network |
| Q36992781 | Detection of influenza antigenic variants directly from clinical samples using polyclonal antibody based proximity ligation assays |
| Q30373706 | Early detection for cases of enterovirus- and influenza-like illness through a newly established school-based syndromic surveillance system in Taipei, January 2010 ~ August 2011 |
| Q64124899 | Effect of propensity of seeking medical care on the bias of the estimated effectiveness of rotavirus vaccines from studies using a test-negative case-control design |
| Q30399334 | Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. |
| Q57210380 | Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: A test-negative case control study |
| Q35758531 | Effectiveness of Trivalent Inactivated Influenza Vaccine in Children Estimated by a Test-Negative Case-Control Design Study Based on Influenza Rapid Diagnostic Test Results |
| Q92665383 | Effectiveness of inactivated influenza vaccine in children by vaccine dose, 2013-18 |
| Q46159620 | Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season |
| Q34993133 | Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination |
| Q30394200 | Effectiveness of seasonal 2008–2009, 2009–2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case–control study |
| Q34274933 | Effectiveness of seasonal influenza vaccinations against laboratory-confirmed influenza-associated infections among Singapore military personnel in 2010-2013. |
| Q30404923 | Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010 |
| Q34451202 | Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies |
| Q30420024 | Effectiveness of seasonal influenza vaccines against influenza-associated illnesses among US military personnel in 2010-11: a case-control approach |
| Q30414952 | Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study |
| Q92437425 | Effectiveness of the quadrivalent inactivated influenza vaccine in Japan during the 2015-2016 season: A test-negative case-control study comparing the results by real time PCR, virus isolation |
| Q35739092 | Effects of different adjuvants in the context of intramuscular and intranasal routes on humoral and cellular immune responses induced by detergent-split A/H3N2 influenza vaccines in mice |
| Q36315363 | Estimates of hospitalization attributable to influenza and RSV in the US during 1997-2009, by age and risk status |
| Q45167252 | Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants |
| Q21144621 | Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study |
| Q45792636 | Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network--pilot case-control studies using different control groups, 2008-2009 season, Spain |
| Q33424462 | Estimation of influenza vaccine effectiveness from routine surveillance data |
| Q33931144 | Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008 |
| Q41637608 | Expected cost effectiveness of high-dose trivalent influenza vaccine in US seniors |
| Q30833500 | Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: test-negative case-control studies using surveillance data, Spain, 2003-2011. |
| Q28393443 | Human and animal sentinels for shared health risks |
| Q37812125 | Human influenza vaccines and assessment of immunogenicity |
| Q33609256 | Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine in US Children 6-35 Months of Age During 2013-2014: Results From A Phase II Randomized Trial. |
| Q47750958 | Immunogenicity and safety of an inactivated quadrivalent influenza vaccine co-administered with a 23-valent pneumococcal polysaccharide vaccine versus separate administration, in adults ≥50years of age: Results from a phase III, randomized, non-infe |
| Q34706925 | Immunologic non-inferiority of a newly licensed inactivated trivalent influenza vaccine versus an established vaccine: a randomized study in US adults |
| Q39671799 | Implementing an influenza vaccination programme for adults aged ≥65 years in Poland: a cost-effectiveness analysis |
| Q53112592 | Importance of timely monitoring of seasonal influenza vaccine effectiveness. |
| Q37778053 | Inactivated split-virion seasonal influenza vaccine (Fluarix): a review of its use in the prevention of seasonal influenza in adults and the elderly |
| Q36115609 | Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine |
| Q42625629 | Influenza A virus in Taiwan, 1980-2006: Phylogenetic and antigenic characteristics of the hemagglutinin gene |
| Q30396318 | Influenza A viruses: why focusing on M2e-based universal vaccines |
| Q42242172 | Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine |
| Q30351995 | Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011 |
| Q28469374 | Influenza Vaccine Effectiveness in the Netherlands from 2003/2004 through 2013/2014: The Importance of Circulating Influenza Virus Types and Subtypes |
| Q33307822 | Influenza activity in Europe during eight seasons (1999-2007): an evaluation of the indicators used to measure activity and an assessment of the timing, length and course of peak activity (spread) across Europe |
| Q30398099 | Influenza antivirals currently in late-phase clinical trial |
| Q35149045 | Influenza epidemiology and vaccine effectiveness among patients with influenza-like illness, viral watch sentinel sites, South Africa, 2005-2009. |
| Q37114545 | Influenza evolution and H3N2 vaccine effectiveness, with application to the 2014/2015 season |
| Q43416256 | Influenza vaccination is not associated with detection of noninfluenza respiratory viruses in seasonal studies of influenza vaccine effectiveness |
| Q47137946 | Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada |
| Q50988284 | Influenza vaccine effectiveness among adult patients in a University of Lyon hospital (2004-2009). |
| Q54523750 | Influenza vaccine in Hajj pilgrims: policy issues from field studies. |
| Q30367695 | Influenza vaccines: a moving interdisciplinary field. |
| Q45351057 | Influenza-related health care utilization and productivity losses during seasons with and without a match between the seasonal and vaccine virus B lineage |
| Q87852509 | Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18 |
| Q42237299 | Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014. |
| Q37011575 | Introduction of a quadrivalent influenza vaccine in Italy: a budget impact analysis |
| Q39857225 | Lessons from the first year of the WAIVE study investigating the protective effect of influenza vaccine against laboratory-confirmed influenza in hospitalised children aged 6-59 months |
| Q30379213 | Lipopeptide vaccines illustrate the potential role of subtype-crossreactive T cells in the control of highly virulent influenza |
| Q35130915 | Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses |
| Q36986520 | MF59 is a safe and potent vaccine adjuvant for flu vaccines in humans: what did we learn during its development? |
| Q37706610 | MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk |
| Q44243917 | Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011. |
| Q30365296 | Mutations associated with severity of the pandemic influenza A(H1N1)pdm09 in humans: a systematic review and meta-analysis of epidemiological evidence. |
| Q47709222 | On the bias of estimates of influenza vaccine effectiveness from test-negative studies |
| Q30401633 | Pandemic influenza H1N1 2009 infection in Victoria, Australia: no evidence for harm or benefit following receipt of seasonal influenza vaccine in 2009. |
| Q30420391 | Pandemism of swine flu and its prospective drug therapy |
| Q26775586 | Patterns of influenza B circulation in Brazil and its relevance to seasonal vaccine composition |
| Q37715313 | Physician surveillance of influenza: collaboration between primary care and public health |
| Q39813068 | Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014. |
| Q34778408 | Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review |
| Q36090140 | Prediction of influenza B vaccine effectiveness from sequence data |
| Q30375714 | Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes. |
| Q84747835 | Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: a randomized, placebo-controlled trial |
| Q51175571 | Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine. |
| Q30406933 | Rapid assessment of influenza vaccine effectiveness: analysis of an internet-based cohort |
| Q30389274 | Role of CD8(+) T-cell immunity in influenza infection: potential use in future vaccine development |
| Q39744811 | Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults |
| Q26781949 | Safety, efficacy, and immunogenicity of Flublok in the prevention of seasonal influenza in adults |
| Q50129178 | Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks |
| Q40990732 | Targeting of nucleoprotein to chemokine receptors by DNA vaccination results in increased CD8(+)-mediated cross protection against influenza |
| Q57792424 | The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People |
| Q90692852 | The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology |
| Q37260000 | The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings |
| Q51225150 | The case test-negative design for studies of the effectiveness of influenza vaccine. |
| Q100528502 | The challenges of vaccine strain selection |
| Q96813808 | The impact of candidate influenza virus and egg-based manufacture on vaccine effectiveness: Literature review and expert consensus |
| Q84927314 | Trivalent and quadrivalent MF59(®)-adjuvanted influenza vaccine in young children: a dose- and schedule-finding study |
| Q30375991 | Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments. |
| Q40722670 | Use of Patients With Diarrhea Who Test Negative for Rotavirus as Controls to Estimate Rotavirus Vaccine Effectiveness Through Case-Control Studies |
| Q30410112 | Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case-control studies, Spain, season 2009-2010. |
| Q45760952 | Variable definitions of the influenza season and their impact on vaccine effectiveness estimates |
| Q38803189 | Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies |
Search more.